Physician profile
Kamran Mohammed Riaz
NPI 1326276965
$198,068.36
in general payments reported to CMS, 2019-2025
23 companies · $43K in 2025
The $43K reported for 2025 was more than what 98% of Cornea and External Diseases Specialist providers received nationally (typical 2025 total: $477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $35K · 2020: $500 · 2021: $496 · 2022: $1,850 · 2023: $40K · 2024: $77K · 2025: $43K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $94K · Consulting Fee: $51K · Travel and Lodging: $10K · Food and Beverage: $4,686.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $94,275.00 |
| Consulting Fee | $50,658.75 |
| Travel and Lodging | $10,298.13 |
| Food and Beverage | $4,685.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $147,925.17 | 2022-2025 | Miebo, Xiidra, Envista Aspire Iol |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $32,071.76 | 2019 | |
| Abbvie INC. | $6,870.06 | 2024-2025 | |
| Carl Zeiss Meditec, INC. | $3,236.11 | 2023-2025 | Visumax, Forum |
| Beaver-Visitec International, INC. | $2,580.53 | 2019-2021 | |
| The Cameron-Ehlen Group, INC. | $1,801.50 | 2021-2022 | |
| Immunogen, INC. | $1,036.78 | 2023 | |
| Johnson & Johnson Surgical Vision, INC. | $619.17 | 2019-2025 | Tecnis Iol |
| Allergan, INC. | $614.03 | 2020-2021 | |
| Mallinckrodt Hospital Products INC. | $306.96 | 2022-2024 | Acthar |
| Alcon Vision LLC | $262.70 | 2019-2025 | Clareon, Tryptyr, Centurion |
| Microsurgical Technology, INC. | $160.76 | 2025 | |
| Ocular Therapeutix, INC. | $153.37 | 2023-2025 | Dextenza |
| New World Medical,INC. | $140.53 | 2025 | Clearpath, Via360, Streamline |
| Merz Pharmaceuticals, LLC | $80.98 | 2023 | Xeomin |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dompe US, INC. | $63.68 | 2019-2024 | Oxervate |
| Harrow Eye, LLC | $33.62 | 2024 | Vevye |
| Kala Pharmaceuticals, INC. | $32.64 | 2019 | |
| Carl Zeiss Meditec USA, INC. | $23.89 | 2022 | |
| Katena Products, INC. (Dba Corza Medical) | $20.68 | 2019 | |
| Rxsight INC | $19.06 | 2023 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Cartridge, Rxsight Injector Handpiece |
| Novartis Pharmaceuticals Corporation | $14.38 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kamran Riaz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.